glp 1 dpp 4 Role of Dipeptidyl Peptidase Inhibitors in Antidiabetic Treatment Oral formulation of DPP-4 inhibitor

Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study Tang, Bowen et al

If you have any concern about potential interactions, consult a medical professional before taking MB-1

Orlistat is an older medication approved for weight loss in 2007 in the UK

Theyve tried dieting

The effects of GLP-1RAs on breast cancer risk Current evidence indicates that GLP-1RAs not only do not increase the risk of breast cancer but may also be associated with a reduced risk of breast cancer development [30]

While treatment guidelines provide evidence-based guidance, they are not prescriptiverather they emphasize individualization of management based on a patients clinical needs and preferences